Literature DB >> 27907217

Natural products from myxobacteria: novel metabolites and bioactivities.

J Herrmann1, A Abou Fayad, R Müller.   

Abstract

Covering: 2011-July 2016Myxobacteria are a rich source for structurally diverse secondary metabolites with intriguing biological activities. Here we report on new natural products that were isolated from myxobacteria in the period of 2011 to July 2016. Some examples of recent advances on modes-of-action are also summarised along with a more detailed overview on five compound classes currently assessed in preclinical studies.

Mesh:

Substances:

Year:  2016        PMID: 27907217     DOI: 10.1039/c6np00106h

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  55 in total

1.  Engineering Pseudochelin Production in Myxococcus xanthus.

Authors:  Juliane Korp; Lea Winand; Angela Sester; Markus Nett
Journal:  Appl Environ Microbiol       Date:  2018-10-30       Impact factor: 4.792

2.  Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase.

Authors:  Colleen E Keohane; Andrew D Steele; Christian Fetzer; Jittasak Khowsathit; Daria Van Tyne; Lucile Moynié; Michael S Gilmore; John Karanicolas; Stephan A Sieber; William M Wuest
Journal:  J Am Chem Soc       Date:  2018-01-24       Impact factor: 15.419

3.  Genome mining reveals uncommon alkylpyrones as type III PKS products from myxobacteria.

Authors:  Joachim J Hug; Fabian Panter; Daniel Krug; Rolf Müller
Journal:  J Ind Microbiol Biotechnol       Date:  2018-12-01       Impact factor: 3.346

4.  Molecular and functional characterization of myxobacteria isolated from soil in India.

Authors:  Shiv Kumar; Arun Kumar Yadav; Priyanka Chambel; Ramandeep Kaur
Journal:  3 Biotech       Date:  2017-05-31       Impact factor: 2.406

Review 5.  Myxobacteria and their products: current trends and future perspectives in industrial applications.

Authors:  Akansha Shrivastava; Rakesh Kumar Sharma
Journal:  Folia Microbiol (Praha)       Date:  2021-05-31       Impact factor: 2.099

6.  An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.

Authors:  Tatyana Dubich; Anna Lieske; Susann Santag; Guillaume Beauclair; Jessica Rückert; Jennifer Herrmann; Jan Gorges; Guntram Büsche; Uli Kazmaier; Hansjörg Hauser; Marc Stadler; Thomas F Schulz; Dagmar Wirth
Journal:  J Mol Med (Berl)       Date:  2019-01-04       Impact factor: 4.599

7.  Isolation of Nannocystis species from Iran and exploring their natural products.

Authors:  Azam Moradi; Mohammad Yaghoubi-Avini; Joachim Wink
Journal:  Arch Microbiol       Date:  2022-01-07       Impact factor: 2.552

8.  Mass spectrometry-based metabolomic signatures of coral bleaching under thermal stress.

Authors:  Ji-Ying Pei; Wen-Feng Yu; Jing-Jing Zhang; Ting-Hao Kuo; Hsin-Hsiang Chung; Jun-Jie Hu; Cheng-Chih Hsu; Ke-Fu Yu
Journal:  Anal Bioanal Chem       Date:  2022-09-05       Impact factor: 4.478

9.  The need to innovate sample collection and library generation in microbial drug discovery: a focus on academia.

Authors:  Antonio Hernandez; Linh T Nguyen; Radhika Dhakal; Brian T Murphy
Journal:  Nat Prod Rep       Date:  2021-03-04       Impact factor: 13.423

10.  Structure and biosynthesis of sorangipyranone - a new γ-dihydropyrone from the myxobacterial strain MSr12020.

Authors:  Dorothy A Okoth; Joachim J Hug; Attila Mándi; Tibor Kurtán; Ronald Garcia; Rolf Müller
Journal:  J Ind Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.